|
1
|
Desitter I, Guerrouahen BS, Benali-Furet
N, Wechsler J, Jänne PA, Kuang Y, Yanagita M, Wang L, Berkowitz JA,
Distel RJ, et al: A new device for rapid isolation by size and
characterization of rare circulating tumor cells. Anticancer Res.
31:427–441. 2011.PubMed/NCBI
|
|
2
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Delloye-Bourgeois C, Fitamant J, Paradisi
A, Cappellen D, Douc-Rasy S, Raquin MA, Stupack D, Nakagawara A,
Rousseau R, Combaret V, et al: Netrin-1 acts as a survival factor
for aggressive neuroblastoma. J Exp Med. 206:833–847. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagrath S, Sequist LV, Maheswaran S, Bell
DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky
A, et al: Isolation of rare circulating tumour cells in cancer
patients by microchip technology. Nature. 450:1235–1239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Munzone E, Botteri E, Sandri MT, Esposito
A, Adamoli L, Zorzino L, Sciandivasci A, Cassatella MC, Rotmensz N,
Aurilio G, et al: Prognostic value of circulating tumor cells
according to immunohistochemically defined molecular subtypes in
advanced breast cancer. Clin Breast Cancer. 12:340–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang S, Lu Z, Unruh AK, Ivan C, Baggerly
KA, Calin GA, Li Z, Bast RC Jr and Le XF: Clinically relevant
microRNAs in ovarian cancer. Mol Cancer Res. 13:393–401. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Krebs MG, Hou JM, Sloane R, Lancashire L,
Priest L, Nonaka D, Ward TH, Backen A, Clack G, Hughes A, et al:
Analysis of circulating tumor cells in patients with non-small cell
lung cancer using epithelial marker dependent and independent
approaches. J Thorac Oncol. 7:306–315. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hiltermann TJ, Pore MM, Van den Berg A,
Timens W, Boezen HM, Liesker JJ, Schouwink JH, Wijnands WJ, Kerner
GS, Kruyt FA, et al: Circulating tumor cells in small-cell lung
cancer: A predictive and prognostic factor. Ann Oncol.
23:2937–2942. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fidler IJ: Tumour heterogeneity and the
biology of cancer invasion and metastasis. Cancer Res.
38:2651–2660. 1978.PubMed/NCBI
|
|
10
|
Scheinin TM and Koivuniemi AP: The
occurrence of cancer cells in blood. Surgery. 51:652–657.
1962.PubMed/NCBI
|
|
11
|
Lee VW, Chiang T and Deodar SD: Bioassay
for quantifying circulating tumour cells in a syngenic mouse model.
Cancer Res. 36:2053–2058. 1976.PubMed/NCBI
|
|
12
|
Karl A, Tritschler S, Hofmann S, Stief CG
and Schindlbeck C: Perioperative search for circulating tumor cells
in patients undergoing radical cystectomy for bladder cancer. Eur J
Med Res. 14:487–490. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao X, Williamson C, Adalsteinsson VA,
D'Agostino RS, Fitton T, Smaroff GG, William RT, Wittrup KD and
Love JC: Tumor cells are dislodged into the pulmonary vein during
lobectomy. J Thorac Cardiovasc Surg. 148:3224–3231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hashimoto M, Tanaka F, Yoneda K, Takuwa T,
Matsumoto S, Okumura Y, Kondo N, Tsubota N, Tsujimura T, Tabata C,
et al: Significant increase in circulating tumour cells in
pulmonary venous blood during surgical manipulation in patients
with primary lung cancer. Interact Cardiovasc Thorac Surg.
18:775–783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hou JM, Greystoke A, Lancashire L,
Cummings J, Ward T, Board R, Amir E, Hughes S, Krebs M, Hughes A,
et al: Evaluation of circulating tumor cells and serological cell
death biomarkers in small cell lung cancer patients undergoing
chemotherapy. Am J Pathol. 175:808–816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hayes DF, Cristofanilli M, Budd GT, Ellis
MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV and
Terstappen LW: Circulating tumor cells at each follow-up time point
during therapy of metastatic breast cancer patients predict
progression-free and overall survival. Clin Cancer Res.
12:4218–4224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cristofanilli M, Hayes DF, Budd GT, Ellis
MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC,
et al: Circulating tumor cells: A novel prognostic factor for newly
diagnosed metastatic breast cancer. J Clin Oncol. 23:1420–1430.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krebs MG, Hou JM, Ward TH, Blackhall FH
and Dive C: Circulating tumour cells: Their utility in cancer
management and predicting outcomes. Ther Adv Med Oncol. 2:351–365.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et
al: Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
